HSP90 as a regulator of extracellular matrix dynamics

被引:18
|
作者
Chakraborty, Abir [1 ]
Edkins, Adrienne Lesley [1 ]
机构
[1] Rhodes Univ, Dept Biochem & Microbiol, Biomed Biotechnol Res Unit BioBRU, ZA-6139 Makhanda Grahamstown, South Africa
基金
新加坡国家研究基金会;
关键词
SHOCK-PROTEIN; 90; HEPARAN-SULFATE PROTEOGLYCANS; SKIN CELL-MIGRATION; TGF-BETA; BREAST-CANCER; FIBRONECTIN; RECEPTOR; INHIBITION; CHAPERONE; INVASION;
D O I
10.1042/BST20210374
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The extracellular matrix (ECM) is a dynamic and organised extracellular network assembled from proteins and carbohydrates exported from the cell. The ECM is critical for multicellular life, providing spatial and temporal cellular cues to maintain tissue homeostasis. Consequently, ECM production must be carefully balanced with turnover to ensure homeostasis; ECM dysfunction culminates in disease. Hsp90 is a molecular chap-erone central to protein homeostasis, including in the ECM. Intracellular and extracellular Hsp90 isoforms collaborate to regulate the levels and status of proteins in the ECM via multiple mechanisms. In so doing, Hsp90 regulates ECM dynamics, and changes in Hsp90 levels or activity support the development of ECM-related diseases, like cancer and fibrosis. Consequently, Hsp90 levels may have prognostic value, while inhibition of Hsp90 may have therapeutic potential in conditions characterised by ECM dysfunction.
引用
收藏
页码:2611 / 2625
页数:15
相关论文
共 50 条
  • [21] HSP90 - The Rosetta stone for cellular protein dynamics?
    DeZwaan, Diane C.
    Freeman, Brian C.
    CELL CYCLE, 2008, 7 (08) : 1006 - 1012
  • [22] Allosteric Modulation of Human Hsp90α Conformational Dynamics
    Penlder, David L.
    Atilgan, Canan
    Bishop, Ozlem Tastan
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2018, 58 (02) : 383 - 404
  • [23] Pharmacological Inhibition of Hsp90 as a Novel Antitumor Strategy to Target Cytoarchitecture Through Extracellular Matrix Signaling
    Chaturvedi, Vishal
    Kumar, Jonnala Ujwal
    Paithankar, Khande Rao
    Vanathi, Perumal
    Sreedhar, Amere Subbarao
    MEDICINAL CHEMISTRY, 2011, 7 (05) : 454 - 465
  • [24] Evolution of the conformational dynamics of the molecular chaperone Hsp90
    Riedl, Stefan
    Bilgen, Ecenaz
    Agam, Ganesh
    Hirvonen, Viivi
    Jussupow, Alexander
    Tippl, Franziska
    Riedl, Maximilian
    Maier, Andreas
    Becker, Christian F. W.
    Kaila, Ville R. I.
    Lamb, Don C.
    Buchner, Johannes
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [25] KLF4 is a novel regulator of the constitutively expressed HSP90
    Ying Liu
    Meidong Liu
    Junwen Liu
    Huali Zhang
    Zizhi Tu
    Xianzhong Xiao
    Cell Stress and Chaperones, 2010, 15 : 211 - 217
  • [26] In Vivo Conformational Dynamics of Hsp90 and Its Interactors
    Chavez, Juan D.
    Schweppe, Devin K.
    Eng, Jimmy K.
    Bruce, James E.
    CELL CHEMICAL BIOLOGY, 2016, 23 (06): : 716 - 726
  • [27] Hsp90: A Global Regulator of the Genotype-to-Phenotype Map in Cancers
    Jarosz, Daniel
    HSP90 IN CANCER: BEYOND THE USUAL SUSPECTS, 2016, 129 : 225 - 247
  • [28] PKCε is a unique regulator for hsp90β gene in heat shock response
    Wu, JM
    Xiao, L
    Cheng, XK
    Cui, LX
    Wu, NH
    Shen, YF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (51) : 51143 - 51149
  • [29] KLF4 is a novel regulator of the constitutively expressed HSP90
    Liu, Ying
    Liu, Meidong
    Liu, Junwen
    Zhang, Huali
    Tu, Zizhi
    Xiao, Xianzhong
    CELL STRESS & CHAPERONES, 2010, 15 (02): : 211 - 217
  • [30] Rationally modified SNX-class Hsp90 inhibitors disrupt extracellular fibronectin assembly without intracellular Hsp90 activity
    Mathenjwa, Gciniwe S.
    Chakraborty, Abir
    Chakraborty, Abantika
    Muller, Ronel
    Akerman, Mathew P.
    Bode, Moira L.
    Edkins, Adrienne L.
    Veale, Clinton G. L.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (10): : 3609 - 3615